Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000778188 | SCV000914352 | uncertain significance | Pyruvate kinase deficiency of red cells | 2018-10-29 | criteria provided, single submitter | clinical testing | The PKLR c.507G>A (p.Gly169Gly) variant has been reported in one study, in which it is found in a compound heterozygous state with a stop-gained variant in one individual with pyruvate kinase deficiency (Fermo et al, 2005). The p.Gly169Gly variant is noted to alter the consensus sequence of a donor splice site. Control data are unavailable for this variant, which is reported at a frequency of 0.000350 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the limited evidence, the p.Gly169Gly variant is classified as a variant of unknown significance but suspicious for pathogenicity for pyruvate kinase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
ARUP Laboratories, |
RCV001811481 | SCV001472917 | uncertain significance | not provided | 2020-08-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001811481 | SCV003808487 | uncertain significance | not provided | 2022-07-07 | criteria provided, single submitter | clinical testing |